|  | Low risk | High-risk No ASD | High-risk ASD |
---|---|---|---|---|
Visit 1 | P400 | |||
 7 months |  Valid trial no. | 57.02 (32.61) | 69.61 (32.15) | 50.18 (30.24) |
 Mean (SD) | 3.11 (4.02) | 1.63 (3.37) | − 2.02 (6.78) | |
  N (girls) | 33 (20) | 23 (18) | 14 (8) | |
AOSI | ||||
 Mean (SD) | 6.70 (3.67) | 9.25 (5.14) | 8.80 (7.39) | |
  N (girls) | 37 (22) | 24 (19) | 15 (8) | |
Mullen ELC | ||||
 Mean (SD) | 102.86 (10.76) | 95.83 (9.88) | 95.40 (18.39) | |
  N (girls) | 37 (22) | 24 (19) | 15 (8) | |
 Age (months) | 7.30 (1.18) | 7.46 (1.22) | 7.47 (1.36) | |
Visit 2 | Disengagement | |||
 14 months |  Valid trial no. | 27.03 (6.64) | 26.86 (7.78) | 24.20 (4.86) |
 Mean (SD) | 144.19 (102.88) | 125.04 (135.13) | 237.05 (122.73) | |
  N (girls) | 36 (22) | 22 (17) | 15 (8) | |
AOSI | ||||
 Mean (SD) | 3.31 (3.57) | 3.30 (3.20) | 7.53 (5.45) | |
  N (girls) | 37 (22) | 23 (18) | 15 (8) | |
Mullen ELC | ||||
 Mean (SD) | 108.46 (15.28) | 104.48 (11.74) | 93.33 (16.29) | |
  N (girls) | 35 (22) | 23 (18) | 15 (8) | |
 Age (months) | 13.72 (1.26) | 13.74 (1.45) | 13.80 (1.94) |